Home > Healthcare > Medical Devices > Implantable Devices > penile implants market
Get a free sample of Penile Implants Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Penile Implants Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Penile Implants Market was valued at around USD 453.1 million in 2023 and is estimated to grow at 4.7% CAGR from 2024 to 2032, due to the rising incidence of erectile dysfunction. For instance, according to the statistics, by 2025, 322 million men are expected to be affected by ED worldwide, a rise from 152 million men in 1995. As more men experience ED, there is a growing demand for effective treatment options, including penile implants. Advances in surgical techniques and penile implant technology have led to improved outcomes and reduced complication rates associated with implantation procedures.
Moreover, growing prevalence of chronic diseases, rising adoption of erectile dysfunction device, advancement in health analytics, rising healthcare expenditure globally, government initiatives and funding, and increasing education & awareness, are the spreading factors fostering the growth of the market.
The market size of penile implants was valued at USD 453.1 million in 2023 and is estimated to grow at a CAGR of over 4.7% from 2024 to 2032, driven by the rising incidence of erectile dysfunction.
Inflatable penile implants market is estimated to account for USD 409.2 million by 2032, as they offer superior functionality compared to semi-rigid or malleable implants.
U.S. penile implants market size will garner 4.4% CAGR through 2032, driven by an advanced healthcare infrastructure with renowned medical centers and hospitals.
Boston Scientific Corporation, Coloplast Corp, Dornier MedTech, Eska Medical Gmbh, Giant Medical LLC, GT Urological, LLC, Owen Mumford Ltd., and Pos-T-Vac, Inc. among others.